Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745870 · ClinicalTrials.gov registry record · Phase 1
Creatine Supplementation and Resistance Training in Premenopausal Females
A Phase 1 study, sponsored by University of Idaho.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT05745870 is a Phase 1 study that has completed, run by University of Idaho. The registered enrollment target is 27 participants.
The verdict
NCT05745870, a Phase 1 study, has completed, sponsored by University of Idaho.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine the effects of creatine monohydrate and resistance training on lean mass, sleep, muscular strength, and perceived menstrual cycle symptoms in untrained premenopausal females. The main questions it aims to answer are: 1) Does creatine monohydrate supplementation improve body composition, muscular strength, and sleep? 2) Does creatine monohydrate decrease perceived menstrual cycle symptoms compared to a placebo control? Participants will be asked to consume creatine monohydrate daily for 42 consecutive days and well as perform a daily ovulation test. Pre and post testing will include assessments of urine specific gravity to determine hydration status, body composition testing, muscular strength testing and questionnaires. Researchers will compare creatine monohydrate supplementation to a maltodextrin control to see if body composition, sleep, muscular strength, and perceived menstrual cycle symptoms are improved following 6-weeks.
Interventions
- DIETARY_SUPPLEMENT Creatine Monohydrate Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-01-20 |
| Est. Completion | 2023-05-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05745870
The ClinicalTrials.gov registry entry for NCT05745870 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Idaho, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Creatine Monohydrate Supplementation is the first listed.
NCT05745870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05745870 about?
NCT05745870 is a clinical study titled "Creatine Supplementation and Resistance Training in Premenopausal Females". The goal of this clinical trial is to determine the effects of creatine monohydrate and resistance training on lean mass, sleep, muscular strength, and perceived menstrual cycle symptoms in untrained premenopausal females. The main questions it aims to answer are: 1) Does creatine monohydrate supple...
What is the current status of trial NCT05745870?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2023-01-20. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT05745870?
The interventions under investigation include: Creatine Monohydrate Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05745870?
This trial is sponsored by University of Idaho, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.